Shockwave Medical, Inc.SWAV

Market cap

P/E ratio

	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Product revenue	43	68	237	490	730
Cost of product revenue	17	21	41	65	95
Gross profit	-	47	196	425	635
Research and development	33	37	51	82	146
Sales and marketing	31	52	111	162	235
General and administrative	14	24	35	57	95
Total operating expenses	95	112	197	301	476
Income (loss) from operations	-52	-66	-1	124	159
Loss from equity method investment	-	-	-6	-2	-2
Interest expense	1	1	1	2	7
Other income (expense), net	-	-	-1	1	24
Net income (loss) before taxes	-51	-66	-9	121	174
Income Tax Expense (Benefit)	0	0	0	-95	27
Net income (loss)	-51	-66	-9	216	147
Unrealized gain (loss) on available-for-sale securities, net of tax	-	-0	-0	-1	1
Adjustment for net gain realized and included in other income, net	-	21,000	-	0	0
Total comprehensive income (loss)	-51	-66	-9	215	148
Basic (USD per share)	-	-	-	6.02	4.01
Diluted (USD per share)	-	-	-	5.7	3.85